GONITRO

Product NDC: 70007-400
11-digit product format: 700070400
Labeler code: 70007
Product ID: 70007-400_677e8d16-0bd2-4cc5-8d23-98e9cc0cf676
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: nitroglycerin
Dosage form: POWDER
Route: SUBLINGUAL
Labeler: Espero Pharmaceuticals, Inc.
Application: NDA208424
Marketing category: NDA
Marketing start: 2016-07-01
Marketing end: 0000-00-00
Substance: NITROGLYCERIN
Active strength: 400 ug/1
Pharmacologic classes: Nitrate Vasodilator [EPC],Nitrates [CS],Vasodilation [PE]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	70007-400		D	Discontinued by firm	2026-08-17
excluded package	package	70007-400	70007-400-12	D	Discontinued by firm	2026-08-17
excluded package	package	70007-400	70007-400-36	D	Discontinued by firm	2026-08-17
excluded package	package	70007-400	70007-400-96	D	Discontinued by firm	2026-08-17
excluded package	package	70007-400	70007-400-99	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 105 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70007-400-12	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70007-400-36	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70007-400-96	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70007-400-99	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70007-400-96	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70007-400-99	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70007-400-36	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70007-400-12	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70007-400-96	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70007-400-99	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70007-400-36	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70007-400-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70007-400-96	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70007-400-99	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70007-400-36	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70007-400-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70007-400-96	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70007-400-99	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70007-400-36	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70007-400-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70007-400-96	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70007-400-99	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70007-400-36	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70007-400-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70007-400-96	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70007-400-99	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70007-400-36	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70007-400-12	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70007-400-96	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70007-400-99	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70007-400-36	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70007-400-12	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70007-400-96	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70007-400-99	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70007-400-36	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70007-400-12	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70007-400-96	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70007-400-99	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70007-400-36	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70007-400-12	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70007-400-96	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70007-400-99	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70007-400-36	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70007-400-12	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70007-400-96	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70007-400-99	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70007-400-36	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70007-400-12	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N208424-001	GONITRO	NITROGLYCERIN	0.4MG/PACKET	POWDER / SUBLINGUAL		RLD	2016-06-08

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N208424-001	9101592	2032-03-11		Drug product	2016-06-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD, RS	2016-06-08	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N208424-001	GONITRO	0.4MG/PACKET	POWDER / SUBLINGUAL	RLD	2016-06-08	`e64feba35796…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N208424-001	9101592	2032-03-11	Drug product	2016-06-28	`e64feba35796…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7480e90b-004b-ebe4-2243-4f2fefdd9e78	Product name	2	20260128
3f158398-73f2-4b90-47d1-5c60e8719a98	Product name	9	20250721
ca6149a6-ded3-9f17-6c41-3e88f2c0c9c0	Product name	2	20250117
00358076-c817-430b-b924-11d717dc307c	Product name	1	20160718
669af5aa-14f3-3df7-f100-5f580ffd43c1	Product name	1	20140508
6ff3bab7-2dce-8bea-d7ce-54687f0c01fb	Product name	1	20140508
8bb82a1c-d0d0-fc27-011f-172e545f0382	Product name	1	20140508
cb03406d-e223-80bb-67d8-be80f9b6a4f2	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
70007-400-12	These highlights do not include all the information needed to use GONITRO safely and effectively. See full prescribing information for GONITRO . GONITRO (nitroglycerin) sublingual powder Initial U.S. Approval: 1981
70007-400-36	These highlights do not include all the information needed to use GONITRO safely and effectively. See full prescribing information for GONITRO . GONITRO (nitroglycerin) sublingual powder Initial U.S. Approval: 1981
70007-400-96	These highlights do not include all the information needed to use GONITRO safely and effectively. See full prescribing information for GONITRO . GONITRO (nitroglycerin) sublingual powder Initial U.S. Approval: 1981
70007-400-99	These highlights do not include all the information needed to use GONITRO safely and effectively. See full prescribing information for GONITRO . GONITRO (nitroglycerin) sublingual powder Initial U.S. Approval: 1981

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
70007-400-01	EA - Each	70007-400	ea2f4bfe-a23c-4eb7-b6cf-0418be4279b8	1	2016-10-06
70007-400-36	EA - Each	70007-400	19f02220-a503-4c7d-9b12-37e5f9b7309b	1	2016-10-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70007-400	GONITRO (NITROGLYCERIN) POWDER [ESPERO PHARMACEUTICALS, INC.]	4	Legacy NDC	20180803_1418d832-4a6a-45ab-8414-25e23f393abb.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
G59M7S0WS3	NITROGLYCERIN	55-63-0	NITROGLYCERIN

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GONITRO - Espero Pharmaceuticals, Inc.	Espero Pharmaceuticals, Inc.	2018-06-20	HUMAN PRESCRIPTION DRUG LABEL	4